Phase II

Efficacy of Guselkumab in the treatment of Hailey Hailey disease: An open-label, proof of concept study

Volunteers
Health Professionals

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Keith Choate

keith.choate@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Keith Choate, MD, PhD
Aaron B. and Marguerite Lerner Professor and Chair of Dermatology. Professor of Genetics and Pathology. Associate Dean for Physician-Scientist Development

Sub-Investigators

Last Updated
07/12/2026
Study IRB
#2000038224